Reach Us +44-2476101207
Journal of Developing Drugs- Open Access Journals
ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Editorial Board
Editor Image

Yavuz S Silay
Therapeutic Medical Head
Teva Neurosciences Commercial Organization

Editor Image

Executive Editor
Walter J Lukiw
Associate Professor
Department of Ophthalmology
Louisiana State University

Editor Image

Executive Editor
Ritu Aneja
Associate Professor
Department of Biology
Georgia State University

Editor Image

Executive Editor
Syed AA Rizvi
Assistant Professor
Department of Pharmaceutical Sciences
Nova Southeastern University

Submit Manuscript

Journal Impact Factor 0.97* Submit manuscript at or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

NLM ID: 101646699; Index Copernicus Value: 62.16 

Journal of Developing Drugs is at higher echelons that enhance the intelligence and information dissemination on topics closely related to Developing Drugs.The Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on an array of Journal of Developing Drugs Research.

The Developing Drugs Peer Reviewed Journals are proficiently supported by universally prominent Editorial Board members. Developing Drugs journal Impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Developing Drugs Open Access Journals are freely accessible to everyone immediately after publication.

Journal of Developing Drugs under Open Access platform focuses on pharmaceuticals coming up through the pipeline and thus aims to advance our understanding of the action of drugs, their harmful effects, prevention and treatment of both existing as well as emerging diseases.

The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing. Journal of Developing Drugs is one of the best Open Access journals of Scholarly publication.

This Pharmaceutical Science Journal adapts to Editorial Manager System for quality in review process. The review process is performed by the editorial board members of Journal of Developing Drugs or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

OMICS International -The scientific hub that possess the unique and the second-to none feature, because of the best published articles and eminent International conferences organized throughout the year. The salient features of are Open Access Journals which are 300, a Team of 25, 000 editorial members along with a reviewing team of 30, 000 and more than 1,00,000 followers on social networks and most essentially 3.0 million readers.The OMICS International

Pharmaceutical Conferences covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality.

Drug Discovery

Drug Discovery focuses on research areas which are related to the discovery and development of new therapeutic entities. Drug Discovery mainly focuses on new compounds and technologies in all aspects of human therapeutics as well as to improve the global management health care policy and regulatory issues. Drug Discovery relates to all the newly technologies in drug development.

Related Journals of Drug Discovery

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Drug Development and Research, Drug Discovery Today, Journal of Drug Discovery, Drug Discovery and Therapeutics, Drug Discovery and Technology, Drug Design and Discovery.

Drug Development

Drug Development in the parent molecule which is having maximum biological activity has been identified during the process of drug discovery and bringing a new pharmaceutical drug to the market. It is the process by which the chemical compound is optimized at the bench on a milligram scale by a medicinal chemist. It can be manufactured on the kilogram on large scale. It is required to establish the physicochemical properties and accelerated stability studies of the new chemical entity.

Related Journals of Drug Development

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Drug Development and Research, Pharmaceutics & Drug Development, Journal of Developing Drugs, Drug Research and Development, Drug Development and Industrial Pharmacy.

Drug Design

Drug Design is the designing of the drug for a particular purpose like DNA-binding, enzyme inhibition etc. Drug Design is a computerized molecular modeling. Drug Design is biological or physical properties of the target studies and a prediction of the sort of chemicals that fit to the active site.

Related Journals of Drug design 

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Drug Designing Journals, Drug Design, Development and Therapy, Chemical Biology & Drug Design, Drug Design & Discovery, Computational Biology and Drug Design, Drug Design, Development and Therapy, Drug Design and Therapy.

Pre-Clinical Drug Development

Pre-clinical drug development is the stage of research that begins before clinical trials where the testing in humans is done can begin during which safety and efficacy of drug data is collected and then accesses the products safety profile.

Related Journals of Pre-clinical drug development

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Toxicology in Preclinical Drug Development, Drug Development Research, Journal of Pharmacology, Pharmaceutical Sciences.

Drug Resistance

Drug Resistance is defined as a significant decrease in response to a drug in a previously susceptible parasite population. Antimicrobial drug resistance is the process that microbe use to tolerate and overcome the effects of antibiotic drugs. As drug resistance grows, combining antibiotics could turn up new treatments. Combining certain antibiotics could help them pack a one-two punch against harmful bacteria and now been used so widely that some of the microbes targeted by the drugs have adapted and become resistant to these drugs that is, the germs are not killed, and their growth is not stopped.

Related Journals of Drug Resistance

Molecular Enzymology and Drug Targets, Journal of Drug Abuse, Drug Metabolism & Toxicology, Pharmacoepidemiology and Drug Safety, Research & Reviews: Drug Delivery


The biomarkers in drug development play an important role in medicine. Biomarkers in Drug Development allow more improvement in the drug safety and efficacy measurements by understanding the mechanism of the diseases and progressive therapeutic intervention is needed. Biomarkers in Drug Development need to be incorporated into continuous cycle from the discovery and development of one series of biomarkers and translates into next series in drug development. Biomarkers in Drug Development Journal focus on different biomarkers development in the field of medicine.

Related Journals of Biomarkers

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Biomarkers Journal, Informa Health Care, Biomarker Research, Biomarkers in Cancer, Biomarkers in Medicine, Biomarkers and Genomic Medicine.

Pharmaceutical Industry

When a single drug comes into market, can expect to have spent $350 million before the drug is available in the market. In most of the large pharmaceutical companies that are working on dozens of drug projects at once spend $5 billion per new medicine to improve the drug efficacy as it tends to fail several times during drug development.

Related Journals of Pharmaceutical Industry

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Pharmaceutical and Biomedical Analysis, Pharmaceutical and Healthcare Marketing, Pharmaceutical Innovation, Pharmaceutical and Biomedical Analysis.

Drug Delivery Systems

Drug Delivery System is the controlled release of therapeutic agents. Drug Delivery System monitors the drug released and the location in the body where it is released. The upcoming drug delivery systems include the researches in the areas of crossing the Blood-Brain Barrier (BBB) in the brain, diseases and disorders, Enhancing targeted intracellular delivery, combining diagnosis and treatment.

Related Journals of Drug Delivery System

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Drug Delivery, Nanopharmaceutics and Drug Delivery, Drug Delivery Science and Technology, Advanced Drug Delivery, Pharmaceutics & Drug Delivery Research, Drug Delivery and Therapeutics.

Drug Interactions

Drug interactions are when one drug interacts with the other drug and produce a pharmacological effect. The effect of the drug can be increased or decreased or cause adverse effects as well. These interactions are kinetic such as absorption, distribution, metabolism and excretion.

Related Journals of Drug Interaction

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Drug Metabolism and Pharmacokinetics, Drug Metabolism and Personalized Therapy, Drug Metabolism and Drug Interactions, Clinical Nutrition.

Drug Therapy

Drug Therapy synonymous to pharmacotherapy is a term used to treat diseases. Drug interacts with a receptor or an enzyme to promote healthy functioning and cure diseases. Medications can be taken as oral pill, capsule or liquid form, or injected into tissues or muscles.

Related Journals of Drug Therapy

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Drug Design, Development and Therapy, Human Pharmacology and Drug Therapy, Current Drug Therapy, Drug Targeting.

Drug Metabolism

Drug Metabolism main aim is to excrete the drug easily. The main centre of drug metabolism is done in liver. Drugs are metabolized by various methods like oxidation, reduction, hydration, hydrolysis, condensation, conjugation or isomerization.

Related Journals of Drug Metabolism

Drug Designing: Open Access, Advances in Pharmacoepidemiology & Drug Safety, Drug Metabolism Toxicology, Drug Metabolism and Pharmacokinetics.

*2018 Journal Impact Factor was established by dividing the number of articles published in 2016 and 2017 with the number of times they are cited in 2018 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2016 and 2017, and 'Y' is the number of times these articles were cited in indexed journals during 2018 then, journal impact factor = Y/X

Recently Published Articles